#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Non-small cell lung cancer metastatic Asthma Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hyperoxaluria Erythema Neuromyelitis optica spectrum disorder Hereditary neuropathic amyloidosis Alagille syndrome Pulmonary alveolar haemorrhage B-cell type acute leukaemia Hypocalcaemia Pemphigus Gastric cancer Lennox-Gastaut syndrome Becker's muscular dystrophy Wiskott-Aldrich syndrome B-cell lymphoma Epstein-Barr virus infection More trials…

    Learn about Rare Diseases

    Gaucher’s disease type III – Treatment Mastocytosis – Basic Information Glycogen storage disease type I – Life with Disease Haemophilia B without inhibitors – Trials in Disease Alagille syndrome – Treatment Urea cycle disorder Focal segmental glomerulosclerosis Hairy cell leukaemia recurrent – Treatment Short-bowel syndrome – Life with Disease Mantle cell lymphoma stage IV – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Dcc-3116 Glucocorticoids Retinol Acetate GEN1078 GSK5764227 Dalteparin Sodium Hydrochlorothiazide Zidovudine Gadoteric Acid Ciprofloxacin Mycophenolate Mofetil Etoricoxib RIVASTIGMINE Panitumumab Upacicalcet Sodium Hydrate Eye103 Bexotegrast Perflubutane Avutometinib ARGININE GLUTAMATE More therapies…

    Learn about Your Condition

    Adenocarcinoma pancreas Aortic stenosis Myelofibrosis Perineal injury Labour pain Embolism venous Tissue anoxia Colorectal cancer Intracranial calcification Synovial sarcoma metastatic Dilated cardiomyopathy Laparoscopic surgery Malignant melanoma stage IV Blood disorder Onychomycosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hemic and Lymphatic Diseases

  • Study of Benralizumab Safety, Pharmacokinetics, and Efficacy in Children with Eosinophilic Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Eosinophilic granulomatosis with polyangiitis
    • Hypereosinophilic syndrome
    Investigated Drugs:
    • Benralizumab
    France The Netherlands Poland

  • Accelerating improvement with teclistamab plus standard drug combination in newly diagnosed transplant‑eligible multiple myeloma patients

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Dexamethasone Acetate
    • Bortezomib
    • Daratumumab
    Germany

  • A Phase III study of NXT007 compared with simoctocog alfa prophylaxis in patients with Hemophilia A without inhibitors

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Simoctocog Alfa
    • Ro7589655
    Austria Denmark France Germany Hungary Italy +3

  • Evaluation of NXT007 versus Emicizumab Prophylaxis in Patients with Hemophilia A

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Factor VIII deficiency
    Investigated Drugs:
    • Emicizumab
    • Ro7589655
    Austria Belgium Denmark France Germany Hungary +5

  • Comparison of Obicetrapib and Bempedoic Acid in Patients with Dyslipidemia at High to Very High Cardiovascular Risk

    Recruiting

    3 1 1
    Investigated Drugs:
    • Obicetrapib
    • Bempedoic Acid
    Czechia Germany Italy The Netherlands Poland Slovakia +1

  • A study to assess the safety of Anumigilimab in adults with sickle cell disease

    Recruiting

    2 1
    Investigated Drugs:
    • ANUMIGILIMAB
    Belgium France Italy The Netherlands
1 2 3 … 89
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!